文献速递临床试验与 GCP流行病学与生物统计

OMERACT-药物依从性干预核心领域集:风湿病学试验的五阶段研究方案

Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
PubMed 文献 · Trials · 2018-03-27

该研究旨在为风湿病学中支持药物依从性的干预试验制定核心领域集。采用五阶段方法:系统综述、患者与照护者半结构化访谈、名义群体技术焦点小组、国际改良德尔菲调查(三轮)以及OMERACT成员利益相关者研讨会。最终将通过共识确定核心领域集,以提升试验证据的可靠性和患者相关性和影响力。

要点

  • 核心领域集应被所有相关试验一致测量,以便系统评价和Meta分析合并数据。
  • 五阶段包括系统综述、访谈、焦点小组、德尔菲调查和共识研讨会。
  • 利益相关者包括患者、照护者、卫生专业人员、研究人员等。

核心结论

  • 建立核心领域集将增强药物依从性干预研究结果的相关性和影响力,并改善风湿病患者的生活。

研究设计与样本

  • 五阶段研究方案:系统综述、半结构化访谈、名义群体技术焦点小组、国际三轮改良德尔菲调查、利益相关者共识研讨会。

临床怎么用

  • 未来风湿病学中支持药物依从性的干预试验应报告该核心领域集所确定的领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the last 20 years, there have been marked improvements in the availability of effective medications for rheumatic conditions such as gout, osteoporosis and rheumatoid arthritis (RA), which have led to a reduction in disease flares and the risk of re-fracture in osteoporosis, and the slowing of disease progression in RA. However, medication adherence remains suboptimal, as treatment regimens can be complex and difficult to continue long term. Many trials have been conducted to improve adherence to medication. Core domains, which are the outcomes of most relevance to patients and clinicians, are a pivotal component of any trial. These core domains should be measured consistently, so that all relevant trials can be combined in systematic reviews and meta-analyses to reach conclusions that are more valid. Failure to do this severely limits the potential for trial-based evidence to inform decisions on how to support medication adherence. The Outcome Measures in Rheumatology (OMERACT) - Interventions for Medication Adherence study by the OMERACT-Adherence Group aims to develop a core domain set for interventions that aim to support medication adherence in rheumatology. METHODS/DESIGN: This OMERACT-Adherence study has five phases: (1) a systematic review to identify outcome domains that have been reported in interventions focused on supporting medication adherence in rheumatology; (2) semi-structured stakeholder interviews with patients and caregivers to determine their views on the core domains; (3) focus groups using the nominal group technique with patients and caregivers to identify and rank domains that are relevant to them, including the reasons for their choices; (4) an international three-round modified Delphi survey involving patients with diverse rheumatic conditions, caregivers, health professionals, researchers and other stakeholders to develop a preliminary core domain set; and (5) a stakeholder workshop with OMERACT members to review, vote on and reach a consensus on the core domain set for interventions to support medication adherence in rheumatology. DISCUSSION: Establishing a core domain set to be reported in all intervention studies undertaken to support patients with medication adherence will enhance the relevance and the impact of these results and improve the lives of people with rheumatic conditions.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kelly A, Tong A, Tymms K, et al. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. 2018. PMID: 29587864. doi:10.1186/s13063-018-2565-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。